I wrote about BD Intelliport back in January. Itâ€™s an impressive system. Others think so, too.
PR Newswire: “Based on its recent analysis of the intravenous drug delivery devices market, Frost & Sullivan recognizes BD with the 2015 North American Frost & Sullivan Award for New Product Innovation. The company’s BD Intelliportâ„¢ System is the industry’s first medication management system designed to overcome long-standing challenges associated with the administration of manual intravenous bolus injections. By offering enhanced automated documentation, dose measurement, drug identification, and real-time allergy alerts to the clinician, the BD Intelliportâ„¢ System is poised to address the most relevant challenges in the intravenous drug delivery market…At the heart of this innovative new system is the BD Intelliportâ„¢ Injection Site, which has a unique barcode reading feature that automatically identifies the medication and concentration contained within a specially encoded syringe as a byproduct of existing clinical workflow. This feature eliminates the need for manual barcode scanning of syringes, enables audible confirmation that the correct drug is about to be given, and facilitates real-time drug allergy checks and alerts. Knowing the exact time each IV injection is given also allows the system to provide accurate and automated re-dosing reminders.”
Thereâ€™s a lot going on with the BD Intelliport System. The key for me however, is its integration to the EHR. Being able to access clinically relevant information and document in real-time is important.
I would like to see BD incorporate this technology into the BD Cato IV Room System. BD Cato is an impressive workflow management system. It offers bar code scan verification, image-assisted documentation, and gravimetrics. What it doesnâ€™t do is record the volume of medication injected into a CSP in real-time. In all fairness, no one offers such a feature.
One has to wonder whether or not anyone at BD has thought about incorporating the CRISI Medical Systems technology into BD Cato. If not, take the hint. At least consider it for chemotherapy and/or other hazardous drug compounding.